Accepted for/Published in: JMIR Research Protocols
Date Submitted: Dec 3, 2023
Date Accepted: Jun 14, 2024
(closed for review but you can still tweet)
The Effectiveness of Medical Adherence mHealth Solutions for individuals with Epilepsy: a systematic review protocol
ABSTRACT
Background:
Epilepsy requires continuous management and treatment for the best patient experience. Advancement of digital health has led to the creation of several eHealth tools aimed at enhancing treatment adherence among individuals with epilepsy. These eHealth solutions for medication adherence provide crucial support, including reminders, educational resources, personalized feedback, assistance with managing costs, shared decision making, and access to supportive communities for those with epilepsy. For designing medication adherence eHealth solutions, it is essential to explore the effectiveness of the current eHealth solutions, identify the roles of healthcare professionals in the digital care pathway, and find the unique circumstances for different patients. As the primary focus of existing studies about epilepsy is on self-management, the effectiveness and usability of medical adherence eHealth solutions are neglected. Moreover, the involvement of healthcare professionals in epileptic digital care pathways as well as the effect of adherence eHealth solutions on patient experience is not explored adequately.
Objective:
This study aims to assess the effectiveness of the current eHealth solutions designed to improve medical adherence in epilepsy patients. Furthermore, it intends to determine the roles of healthcare professionals within eHealth systems aimed at supporting epilepsy patients’ adherence to medication. Finally, this review examines the experiences of patients utilizing eHealth solutions for maintaining medical adherence in epilepsy care.
Methods:
The objective of this study is to develop a thorough summary of existing research and evidence on eHealth solutions for medical adherence in epilepsy. Therefore, a systematic literature review (SLR) has been selected to address the research questions, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA statement) guidelines. The exclusion and inclusion criteria are carefully chosen, and both qualitative and quantitative analysis will be used for the analysis of the results.
Results:
The initial search and full paper screening is carried out and the pilot study is in progress. The expected results mainly focus on the comparison, classification and the analysis of the effectiveness of the current medical adherences. Moreover, the role of healthcare professionals in epileptic digital care pathway with emphasis on medical adherences would be explored. Finally, the patient experiences using the current medical adherence for epilepsy will be assessed.
Conclusions:
To enhance the digital care pathway for epilepsy, a medical adherence eHealth solution should be personalized, manage medications, include an alarm system, track seizures, support consultations, and offer updated treatment plans. This study aims to understand how findings from the research questions can enhance eHealth solutions for individuals with epilepsy. Insights from this research about the effectiveness of current adherence solutions provides a guideline for the development of future eHealth systems, making them more efficient and effective for managing epilepsy. Clinical Trial: PROSPERO 2023 CRD42023474008 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023474008
Citation
Request queued. Please wait while the file is being generated. It may take some time.